Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Vascular Biogenics

Vascular Biogenics reported $-3297000 in EBIT for its fiscal quarter ending in March of 2023.

Ebit Change
Bluebird Bio BLUE:US USD -84493000 7.93M
Infinity Pharmaceuticals INFI:US USD -11507000 1.97M
Lumos Pharma Inc. NLNK:US USD -8035000 800K
Vascular Biogenics VBLT:US USD -3297000 103K